COMMENT

insight

Accelerated approval designations in China

Only two accelerated approval designations have been awarded in China since 2015, despite an increase in other drug designations

insight

Accelerated approval designations in China

Only two accelerated approval designations have been awarded in China since 2015, despite an increase in other drug designations

insight

Europe reports the highest prevalence of chronic cough

comment

Could vaccine hesitancy impact hearing disorders?

Go to article: Home | Drug dealing goes digital Go to article: In this issueGo to article: ContentsGo to article: SyrenisGo to article: Astrix Go to article: BriefingGo to article: Industry newsGo to article: The pharma industry briefingGo to article: Covid-19 executive briefing by GlobalDataGo to article: Thermo Fisher Scientific Company InsightGo to article: Thermo Fisher ScientificGo to article: CommentGo to article: Life sciences professionals prioritise quality over cost for PV automationGo to article: Slow progress for male contraceptive trialsGo to article: Accelerated approval designations in ChinaGo to article: Mimotopes Company Insight Go to article: MimotopesGo to article: In DepthGo to article: The dark consequences of supply shortagesGo to article: Digitising the pharma supply chainGo to article: Covid-19 vaccine pricing varies wildly by country and company Go to article: Psychedelics and mental health: the next big thing?Go to article: Schizophrenia drug landscape: a stagnant field on the cusp of change?Go to article: Are supercomputers set to transform pharma R&D?Go to article: BEA TechnologiesGo to article: LabcorpGo to article: In DataGo to article: North America's AI hiring boomGo to article: The pharma companies leading the way in artificial intelligenceGo to article: Global markets and indicesGo to article: Macro-economic indicatorsGo to article: Macro-economic indicators (page 2)Go to article: EventsGo to article: Next issue